IP Verse

Strawman competitive analysis

Explore patent oppositions filed by Strawman against competitors, revealing strategic technology disputes and market positioning.

Last updated on: May 28, 2026

Patent Number	Title	Applicant	Opposition Date
EP3752238	Expandable Introducer Sheath For Medical Device	ABIOMED	Apr 9, 2026
EP4021235	Impact Mitigating Structure	HEXR	Mar 25, 2026
EP4223311	Individualized Vaccines For Cancer	BIONTECH	Mar 24, 2026
EP3673899	Nasal Powder Formulation For Treatment Of Hypoglycemia	AMPHASTAR PHARMACEUTICALS	Mar 19, 2026
EP3673900	Nasal Powder Formulation For Treatment Of Hypoglycemia	AMPHASTAR PHARMACEUTICALS	Mar 19, 2026
EP3635408	Methods For Predicting The Usefulness Of Disease Specific Amino Acid Modifications For Immunotherapy	BIONTECH	Jan 30, 2026
EP4186927	Methods And Compositions For Modifying Macrophage Polarization Into Pro-Inflammatory Cells To Treat Cancer	OSE IMMUNOTHERAPEUTICS	Jan 16, 2026
EP4349407	5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating Major Depression	GH RESEARCH IRELAND	Jan 9, 2026
EP3407884	Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression Innpm1	MEMORIAL SLOAN KETTERING CANCER CENTER	Jan 7, 2026
EP3928646	Vaporization Device Systems And Methods	JUUL LABS	Dec 23, 2025

Discover the latest PTAB cases involving Strawman, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Strawman with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: May 28, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
STRAWMAN	357	-	-	-
AMGEN	8	139	8	11
CHUGAI SEIYAKU KABUSHIKI KAISHA	3	82	-	1
NOVARTIS	6	441	-	21